comparemela.com

Latest Breaking News On - Jeff cislini - Page 1 : comparemela.com

Bellevue Group AG Boosts Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […]

Jack-anders
Raymond-james
Jeff-cislini
Piper-sandler
Bellevue-group
Nasdaq
Revolution-medicines-inc
Exchange-commission
Securities-exchange-commission
Bain-capital-life-sciences-investors
Rafferty-asset-management
Investment-management

Bain Capital Life Sciences Investors LLC Takes Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bain Capital Life Sciences Investors LLC bought a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines accounts for 3.1% of Bain Capital Life […]

Alger
Algeria
Jack-anders
Piper-sandler
Raymond-james
Jeff-cislini
Clear-harbor-asset-management
Securities-exchange-commission
Needham-company
Hermes-inc
Bain-capital-life-sciences-investors
Fred-alger-management

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $43.20 Average Target Price from Brokerages

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been given an average rating of “Buy” by the ten analysts that are currently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target […]

Piper-sandler
Jeff-cislini
Sushil-patel
Raymond-james
Nasdaq
Revolution-medicines-inc
Janus-henderson-group
Securities-exchange-commission
Revolution-medicines-company-profile
Needham-company
Paloma-partners-management-co
Farallon-capital-management

Revolution Medicines (NASDAQ:RVMD) Sets New 52-Week High at $40.63

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $40.63 and last traded at $40.05, with a volume of 295845 shares trading hands. The stock had previously closed at $39.66. Analyst Upgrades and Downgrades Several research analysts have issued reports […]

Switzerland
Texas
United-states
Swiss
Raymond-james
Jack-anders
Jeff-cislini
Piper-sandler
Needham-company
Revolution-medicines-inc
Proshare-advisors
Swiss-national-bank

Wedbush Boosts Revolution Medicines (NASDAQ:RVMD) Price Target to $46.00

Wedbush Boosts Revolution Medicines (NASDAQ:RVMD) Price Target to $46.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Texas
United-states
China
Swiss
Piper-sandler
Raymond-james
Jeff-cislini
Jack-anders
China-universal-asset-management-co
Needham-company
Headlands-technologies
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.